Azacitidine - Docslib

214120Orig1s000
Intravesical Instillation of Azacitidine Suppresses Tumor Formation Through TNF-R1 and TRAIL-R2 Signaling in Genotoxic Carcinogen-Induced Bladder Cancer
LEUKEMIA CHEMOTHERAPY REGIMENS (Part 1 of 2) the Selection, Dosing, and Administration of Anti-Cancer Agents and the Management of Associated Toxicities Are Complex
Vidaza, INN-Azacitidine
Label (PDF)
Azacytidine Sensitizes Acute Myeloid Leukemia Cells to Arsenic Trioxide By
Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: from Discovery to Implementation
Vidaza U.S. Full Prescribing Information
Current Treatment of Juvenile Myelomonocytic Leukemia
A Phase II Study of Omacetaxine (OM) in Patients with Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure 2013-0870
Sorafenib and Omacetaxine Mepesuccinate As a Safe and Effective Treatment for Acute Myeloid Leukemia Carrying Internal Tandem Du
Treating Acute Myeloid Leukemia (AML) If You've Been Diagnosed with Acute Myeloid Leukemia (AML), Your Cancer Care Team Will Discuss Your Treatment Options with You
Antiproliferative and Antitumor Effects of Azacitidine Against the Human Myelodysplastic Syndrome Cell Line SKM-1
Acute Myeloid Leukemia (AML) Treatment Regimens
Vidaza® (Azacitidine)
Myelodysplastic Syndrome
Cancer Drug Costs for a Month of Treatment at Initial Food
Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?

Top View